Moderna and Merck's cancer vaccine: How does it work?

Drugmakers Moderna and Merck have scored a breakthrough with a personalised cancer vaccine that doctors hope could eventually work against many types of cancers. The companies said their vaccine helped prevent the recurrence and spread of melanoma – the deadliest form of skin cancer. Moderna expects thousands of melanoma patients could benefit within the first few years of the treatment being approved. Brandon Wainwright, a professor at The University of Queensland’s Institute for Molecular Bioscience, tells CNA's Asia Now he has “enormous optimism” about the technology and discusses its potential to target other cancers. Subscribe to our channel here: https://cna.asia/youtubesub Visit our website: https://cna.asia Download our app: https://cna.asia/app Get our editors' picks of stories via chat apps: Telegram: https://cna.asia/telegram WhatsApp: https://cna.asia/whatsapp Follow us on these platforms: https://www.facebook.com/channelnewsasia https://www.instagram.com/channelnewsasia https://www.tiktok.com/@channelnewsasia